Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR)

OBJECTIVES: We conducted a subanalysis of data from the multicentre, retrospective observational Nivolumab Japan Real World (CA209-9CR) study to evaluate nivolumab effectiveness and safety in elderly patients (aged ≥75 years) with advanced/metastatic non-small cell lung cancer. MATERIALS AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Okishio, Kyoichi, Morita, Ryo, Shimizu, Junichi, Saito, Haruhiro, Sakai, Hiroshi, Kim, Young Hak, Hataji, Osamu, Yomota, Makiko, Nishio, Makoto, Aoe, Keisuke, Kanai, Osamu, Kumagai, Toru, Kibata, Kayoko, Tsukamoto, Hiroaki, Oizumi, Satoshi, Fujimoto, Daichi, Tanaka, Hiroshi, Mizuno, Keiko, Masuda, Takeshi, Kozuki, Toshiyuki, Haku, Takashi, Suzuki, Hiroyuki, Okamoto, Isamu, Hoshiyama, Hirotoshi, Yada, Nobumichi, Ohe, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373314/
https://www.ncbi.nlm.nih.gov/pubmed/32690620
http://dx.doi.org/10.1136/esmoopen-2019-000656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373314/
https://www.ncbi.nlm.nih.gov/pubmed/32690620
http://dx.doi.org/10.1136/esmoopen-2019-000656

Ejemplares similares